trastuzumab deruxtecan
daiichi sankyo,sanofi,astrazeneca,seagen
['enhertu', '$azn', '$sgen', '$sny']
after enhertu's success, who else is looking at her2-low? it's a pretty short list. what have i missed? my quick take via (click link for full list!) $azn $dnsky $sgen $sny $alxo #asco22 
Pharma and biotech reporter, found a home at Evaluate Vantage.